INVIVO STUDIES ON THE UTILIZATION OF MONO-L-ASPARTYL CHLORIN (NPE6) FOR PHOTODYNAMIC THERAPY
- 1 September 1987
- journal article
- research article
- Vol. 47 (17), 4681-4685
Abstract
The in vivo photosensitizing efficacy of mono-L-aspartyl chlorin has been studied by determining the percentage of BALB/c mice cured at varying doses of drug. Using an EMT-6 tumor model, animals received i.p. injections of mono-L-aspartyl chlorin (0.5-100 mg/kg) and then were subsequently exposed to light at 664 nm. Tumor biopsies were taken from selected animals sacrificed at 24 h after treatment and routine histopathological sections made. The other animals remained in the dark for a period of 6 weeks to determine the cure rate. Our results show that mono-L-aspartyl chlorin is an effective tumor localizer that brings about the selective degradation of tumor tissue following light exposure.This publication has 8 references indexed in Scilit:
- Study of the in vivo and in vitro photosensitizing capabilities of uroporphyrin I compared to photofrin IILasers in Surgery and Medicine, 1986
- Comparison of Fluorescence and Photodynamic Activities of Whole Hematoporphyrin Derivative and Its Enriched Active Components2JNCI Journal of the National Cancer Institute, 1985
- HISTOPATHOLOGICAL COMPARISON OF THE EFFECTS OF HEMATOPORPHYRIN DERIVATIVE ON 2 DIFFERENT MURINE TUMORS USING COMPUTER-ENHANCED DIGITAL VIDEO FLUORESCENCE MICROSCOPY1985
- TUMOR DESTRUCTION AND KINETICS OF TUMOR-CELL DEATH IN 2 EXPERIMENTAL MOUSE-TUMORS FOLLOWING PHOTODYNAMIC THERAPY1985
- Hematoporphyrin Derivative and Laser Photoradiation in the Treatment of Lung CancerChest, 1982
- Uptake of hematoporphyrin derivative and sensitized photoinactivation of C3H cells with different oncogenic potentialCancer Letters, 1981
- Photoradiation in the Treatment of Recurrent Breast Carcinoma2JNCI Journal of the National Cancer Institute, 1979
- PHOTORADIATION THERAPY FOR TREATMENT OF MALIGNANT-TUMORS1978